159 related articles for article (PubMed ID: 18348865)
1. Redox-mediated modification of PLZF by SUMO-1 and ubiquitin.
Kang SI; Choi HW; Kim IY
Biochem Biophys Res Commun; 2008 May; 369(4):1209-14. PubMed ID: 18348865
[TBL] [Abstract][Full Text] [Related]
2. Modification of promyelocytic leukemia zinc finger protein (PLZF) by SUMO-1 conjugation regulates its transcriptional repressor activity.
Kang SI; Chang WJ; Cho SG; Kim IY
J Biol Chem; 2003 Dec; 278(51):51479-83. PubMed ID: 14527952
[TBL] [Abstract][Full Text] [Related]
3. Regulation of SUMOylation by reversible oxidation of SUMO conjugating enzymes.
Bossis G; Melchior F
Mol Cell; 2006 Feb; 21(3):349-57. PubMed ID: 16455490
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-32α modulates promyelocytic leukemia zinc finger gene activity by inhibiting protein kinase Cɛ-dependent sumoylation.
Park YS; Kang JW; Lee DH; Kim MS; Bak Y; Yang Y; Lee HG; Hong J; Yoon DY
Int J Biochem Cell Biol; 2014 Oct; 55():136-43. PubMed ID: 25178676
[TBL] [Abstract][Full Text] [Related]
5. SUMO modification modulates the transrepression activity of PLZF.
Chao TT; Chang CC; Shih HM
Biochem Biophys Res Commun; 2007 Jun; 358(2):475-82. PubMed ID: 17498654
[TBL] [Abstract][Full Text] [Related]
6. A Kruppel zinc finger of ZNF 146 interacts with the SUMO-1 conjugating enzyme UBC9 and is sumoylated in vivo.
Antoine K; Prosperi MT; Ferbus D; Boule C; Goubin G
Mol Cell Biochem; 2005 Mar; 271(1-2):215-23. PubMed ID: 15881673
[TBL] [Abstract][Full Text] [Related]
7. Modification of de novo DNA methyltransferase 3a (Dnmt3a) by SUMO-1 modulates its interaction with histone deacetylases (HDACs) and its capacity to repress transcription.
Ling Y; Sankpal UT; Robertson AK; McNally JG; Karpova T; Robertson KD
Nucleic Acids Res; 2004; 32(2):598-610. PubMed ID: 14752048
[TBL] [Abstract][Full Text] [Related]
8. MEL-18 interacts with HSF2 and the SUMO E2 UBC9 to inhibit HSF2 sumoylation.
Zhang J; Goodson ML; Hong Y; Sarge KD
J Biol Chem; 2008 Mar; 283(12):7464-9. PubMed ID: 18211895
[TBL] [Abstract][Full Text] [Related]
9. The promyelocytic leukemia zinc finger protein down-regulates apoptosis and expression of the proapoptotic BID protein in lymphocytes.
Parrado A; Robledo M; Moya-Quiles MR; Marín LA; Chomienne C; Padua RA; Alvarez-López MR
Proc Natl Acad Sci U S A; 2004 Feb; 101(7):1898-903. PubMed ID: 14769944
[TBL] [Abstract][Full Text] [Related]
10. In vitro modification of human centromere protein CENP-C fragments by small ubiquitin-like modifier (SUMO) protein: definitive identification of the modification sites by tandem mass spectrometry analysis of the isopeptides.
Chung TL; Hsiao HH; Yeh YY; Shia HL; Chen YL; Liang PH; Wang AH; Khoo KH; Shoei-Lung Li S
J Biol Chem; 2004 Sep; 279(38):39653-62. PubMed ID: 15272016
[TBL] [Abstract][Full Text] [Related]
11. SUMOylation of the transcription factor ZFHX3 at Lys-2806 requires SAE1, UBC9, and PIAS2 and enhances its stability and function in cell proliferation.
Wu R; Fang J; Liu M; A J; Liu J; Chen W; Li J; Ma G; Zhang Z; Zhang B; Fu L; Dong JT
J Biol Chem; 2020 May; 295(19):6741-6753. PubMed ID: 32249212
[TBL] [Abstract][Full Text] [Related]
12. Ubc9-mediated sumoylation leads to transcriptional repression of IRF-1.
Kim EJ; Park JS; Um SJ
Biochem Biophys Res Commun; 2008 Dec; 377(3):952-6. PubMed ID: 18955028
[TBL] [Abstract][Full Text] [Related]
13. The promyelocytic leukemia zinc finger (PLZF) protein exerts neuroprotective effects in neuronal cells and is dysregulated in experimental stroke.
Seidel K; Kirsch S; Lucht K; Zaade D; Reinemund J; Schmitz J; Klare S; Li Y; Schefe JH; Schmerbach K; Goldin-Lang P; Zollmann FS; Thöne-Reineke C; Unger T; Funke-Kaiser H
Brain Pathol; 2011 Jan; 21(1):31-43. PubMed ID: 20731660
[TBL] [Abstract][Full Text] [Related]
14. Sumoylation of internally initiated Sp3 isoforms regulates transcriptional repression via a Trichostatin A-insensitive mechanism.
Spengler ML; Kennett SB; Moorefield KS; Simmons SO; Brattain MG; Horowitz JM
Cell Signal; 2005 Feb; 17(2):153-66. PubMed ID: 15494207
[TBL] [Abstract][Full Text] [Related]
15. Nucleus accumbens associated 1 is recruited within the promyelocytic leukemia nuclear body through SUMO modification.
Tatemichi Y; Shibazaki M; Yasuhira S; Kasai S; Tada H; Oikawa H; Suzuki Y; Takikawa Y; Masuda T; Maesawa C
Cancer Sci; 2015 Jul; 106(7):848-56. PubMed ID: 25891951
[TBL] [Abstract][Full Text] [Related]
16. SUMO modification of NZFP mediates transcriptional repression through TBP binding.
Kim M; Chen Z; Shim MS; Lee MS; Kim JE; Kwon YE; Yoo TJ; Kim JY; Bang JY; Carlson BA; Seol JH; Hatfield DL; Lee BJ
Mol Cells; 2013 Jan; 35(1):70-8. PubMed ID: 23269432
[TBL] [Abstract][Full Text] [Related]
17. Small ubiquitin-like modifier (SUMO) modification of E1 Cys domain inhibits E1 Cys domain enzymatic activity.
Truong K; Lee TD; Chen Y
J Biol Chem; 2012 May; 287(19):15154-63. PubMed ID: 22403398
[TBL] [Abstract][Full Text] [Related]
18. The Promyelocytic Leukemia Zinc Finger (PLZF ) gene is a novel transcriptional target of the CCAAT-Displacement-protein (CUX1) repressor.
Fréchette I; Darsigny M; Brochu-Gaudreau K; Jones C; Boudreau F
FEBS J; 2010 Oct; 277(20):4241-53. PubMed ID: 20945532
[TBL] [Abstract][Full Text] [Related]
19. SUMO modification is required for in vivo Hox gene regulation by the Caenorhabditis elegans Polycomb group protein SOP-2.
Zhang H; Smolen GA; Palmer R; Christoforou A; van den Heuvel S; Haber DA
Nat Genet; 2004 May; 36(5):507-11. PubMed ID: 15107848
[TBL] [Abstract][Full Text] [Related]
20. Control of SUMO and Ubiquitin by ROS: Signaling and disease implications.
Stankovic-Valentin N; Melchior F
Mol Aspects Med; 2018 Oct; 63():3-17. PubMed ID: 30059710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
